Digital Pathology Market

The digital pathology market is projected to reach USD  2.0 billion by 2029 from USD  1.1 billion in 2024, at a CAGR 13.1% from 2024  to 2029. The global shortage of pathologists has emerged as a critical driver for the digital pathology solutions market. Currently, over 102,000 pathologists are unevenly spread across more than 130 countries, with two-thirds concentrated in just 10 nations. This uneven distribution of pathologists across regions, where some areas manage large workloads while others face severe shortages and resulting delays, contributes significantly to the increasing demand for digital pathology solutions. In addition, market growth is fueled by advancements in image analysis algorithms, artificial intelligence (AI) applications for pattern recognition, and cloud-based solutions that enhance scalability and accessibility. However, lack of trained pathologits and high capital investment limits the adoption of digital pathology solutions.

The Digital pathology market is fairly competitive market and is dominated by key players. The major players operating in this market are Danaher Corporation (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics K.K. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Huron Digital Pathology (Canada), Hologic, Inc. (US), Corista (US), Indica Labs Inc. (US), Objective Pathology Services Limited (Canada), Sectra AB (Sweden), OptraSCAN (US), Akoya Biosciences, Inc. (US), Glencoe Software, Inc. (US), Aiforia (Finland), Paige AI, Inc. (US), Fujifilm Holdings Corporation (Japan), Proscia Inc. (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Mikroscan Technologies, Inc. (US), PathAI (US), Motic Digital Pathology (US), and Kanteron Systems (Spain).

To know about the assumptions considered for the study download the pdf brochure

Danaher Corporation (US)

Danaher Corporation has established itself as a strong player in the digital pathology market. Its subsidiary, Leica Biosystems, offers a portfolio from biopsy to diagnosis across radiology, pathology, surgery, and oncology. The company’s strategic partnerships and collaborations have significantly bolstered its position as a leading player in the digital pathology market. For instance, in March 2023, the company partnered with Paige (US), a global leader in end-to-end digital pathology solutions and clinical AI application; to enhance the use of digital pathology workflows at hospitals and laboratories. Moreover, the company has collaborated with the European Society for Digital and Integrative Pathology (ESDIP) to promote the adoption of digital pathology across Europe. Such initiatives, have played a pivotal role in solidifying its leadership in the digital pathology market, fostering continuous growth and innovation in diagnostic technologies

Koninklijke Philips N.V. (Netherlands)

Philips has established itself as a prominent player in the digital pathology market by offering a comprehensive solution that significantly enhances efficiency, collaboration, and diagnostic accuracy for pathologists worldwide. Their digital pathology solution enables pathologists to work more efficiently by transitioning from traditional microscopy to digital workflows. This transition has shown efficiency gains of up to 15-20% per case, allowing pathologists to handle more cases in less time without compromising accuracy. By digitizing pathology processes, Philips facilitates remote and collaborative working environments where pathologists can reach diagnostic consensus more effectively.  Moreover, Philips addresses the global shortage of trained pathologists by providing tools that streamline workflows and enable multidisciplinary collaboration. Their solution enables remote consultation, real-time case sharing, and multidisciplinary discussions among clinical teams, which are essential for comprehensive patient care. With insights gathered from more than 300 customers and over 20 hospital pathology laboratories, Philips has refined its digital pathology solution to meet the diverse needs of healthcare providers.

Hamamatsu Photonics K.K. (Japan)

Hamamatsu Photonics has solidified its position in the digital pathology market. The company achieve an annual growth rate of 4.4% in medical-bio instruments from 2021 to 2023. The company’s strategic choices such as developments in expanding its product portfolio for digital pathology solutions and significant R&D investments are expected to propel its growth in the coming years. For instance, in March 2023, the company has signed a major distribution deal with Siemens Healthinners to provide its imaging slide scanners for digital pathology in the America and European region. This partnership is expected to enable Siemens Healthineers to bridge the gap between radiology and pathology, unlocking the full capabilities of digital operations to enhance patient care. This strategic collaboration underscores Hamamatsu's commitment to advancing diagnostic imaging solutions and underscores its role as a key player in shaping the future of digital pathology for improved patient care outcomes.

Related Reports:

Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]